Fortrea and Omico collaboration to advance biomarker-led oncology drug development
FTRE•Fortrea and Omico are collaborating to advance biomarker-led oncology drug development.
1. Collaboration announced
Fortrea and Omico announced a collaboration to advance biomarker-led oncology drug development.
